CapitalCube*Disclaimer : This is as of previous day’s closing price.
Technical Indicators
Below is a quick look at 5 technical indicators for Intra-Cellular Therapies, Inc.. More studies are available on the Technical Chart.
| Indicator | Signal |
|---|---|
| Closing Price above/below 50 Day Moving Average | Bearish |
| Closing Price above/below 200 Day Moving Average | Bearish |
| 50 Day Moving Average above/below 200 Day Moving Average | Bearish |
| RSI Reading Level (<30 or >70) | Fair Value |
| MACD Compared to 9D EMA Signal Line | Bearish |
View these and more technical studies for Intra-Cellular Therapies, Inc.
Share Price Performance Relative to Peers
From a peer analysis angle, relative underperformance over the last year has improved more recently.
ITCI-US‘s share price performance of -72.72% over the last 12 months is below its peer median. However, its 30-day trend of -9.42% is now around the peer median suggesting that the company’s recent performance has improved relative to peers.
Quadrant label definitions. Hover to know more
Screen for companies using relative share price performance
Earnings Momentum
Intra-Cellular Therapies, Inc. has an earnings score of 71.48 and has a relative valuation of OVERVALUED.
Stocks with High Earnings Momentum are a preferred option for momentum plays. If they are undervalued, it can be a further advantage and may indicate sustained momentum.
Quadrant label definitions. Hover to know more
Screen for companies using Earnings Momentum Score